Novartis India Ltd


BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 
Market Cap: [Rs.Cr.] 1,598 | Face Value: [Rs.] 5
Industry: Pharmaceuticals - Multinational

 Discuss this stock

Half Yearly Results

ParticularsMar-13
(Rs.Cr) 
Sep-12
(Rs.Cr) 
Mar-12
(Rs.Cr) 
Gross Sales 429457410
Other Income  424147
Total Income 488498472
Total Expenditure  415399367
PBIDT 74100106
Interest  000
PBDT 74100105
Depreciation 222
Tax 183234
Deferred Tax 00-2
Reported Profit After Tax 536671
Extra-ordinary Items  000
Adjusted Profit After Extra-ordinary item 536671
    
EPS (Unit Curr.) 16.720.822.3
EPS (Adj) (Unit Curr.) 16.720.822.3
Calculated EPS (Unit Curr.) 16.720.822.3
Calculated EPS (Adj) (Unit Curr.) 16.720.822.3
Calculated EPS (Ann.) (Unit Curr.) 33.441.544.6
Calculated EPS (Adj) (Ann.) (Unit Curr.) 33.441.544.6
Book Value (Unit Curr.) 0.00.00.0
Dividend (%) 0.00.00.0
Equity 161616
Reserve & Surplus 0.00.00.0
Face Value 5.05.05.0
    
Non-Promoter Holding Shares 7,535,9957,535,9957,535,995
Non-Promoter Holding (%) 23.5823.5823.58
    
PBIDTM(%) 17.1521.8025.72
PBDTM(%) 17.1321.7725.65
PATM(%) 12.4514.5117.36
 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Glaxosmit Pharma 19,207.00 29.02 9.56 18.86 34.3 45.2 0.00
Sanofi India 5,688.41 31.44 4.77 13.73 15.4 22.5 0.00
Pfizer 3,126.19 15.17 1.83 9.41 15.0 22.1 0.00
Abbott India 3,070.09 18.49 4.75 12.08 24.3 34.8 0.00
Fres.Kabi Onco. 1,976.71 22.04 3.34 22.38 3.5 5.4 0.42
Wyeth 1,771.48 13.62 3.09 7.61 33.4 45.1 0.01
Astrazeneca Phar 1,729.88 0.00 17.34 140.28 10.7 15.2 0.03
Novartis India 1,597.68 13.34 1.77 10.43 20.0 28.8 0.00
Merck 1,079.08 13.49 2.23 7.04 17.5 25.5 0.00
Fulford (India) 247.65 0.00 1.71 0.00 -3.4 -4.7 0.00
Organon (India) 159.14 0.00 0.98 0.00 15.3 22.8 0.00

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

C Snook , Chairman 

R Shahani , Vice Chairman & M.D. 

J Hiremath , Director 

R Mehrotra , Director 


Company Head Office / Quarters:
Sandoz House Shivsagar Estate,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400018
Phone : 91-022-24988888/4802/4040/24958400
Fax : 91-022-24938666/24970361
E-mail : hemang.maniar@novartis.com
Web : http://www.novartis.co.in
Registrars:
Sharepro Services India P Ltd
Samhita Complex
Plot No 13 AB
Saki Naka Andheri(E)
Mumbai-400072

Fund Holding

 
Scheme Name No. of Shares
SBI Pharma Fund (D) 17,312

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Open : India Finsec
Economic Events
list No economic event today
Results
list Bharat Forge | Oil India | Container Corpn.